Mukka Proteins Announces Strategic Investment in Aqua Marine to Expand Core Business
Mukka Proteins Limited has approved a strategic investment in Aqua Marine, a manufacturing firm specializing in fish meals and fish oil. The acquisition aims to expand the company's core business by focusing on capacity expansion and optimizing operational processes to achieve improved production efficiency and broader market reach.The company plans to acquire a 51% stake in Aqua Marine through a capital contribution structured in one or more tranches. The investment amount is not exceeding Rs. 15,00,00,000/- (Rupees Fifteen Crores Only).
Mukka Proteins Limited determined that the proposed investment aligns with its strategic plans for business expansion. This move is part of a broader effort to strengthen its market presence within the industry segment. The acquisition is scheduled for completion by 30-09-2026 and is being executed via cash consideration.
The target entity, Aqua Marine, operates in the manufacturing of fish meals and fish oil. Established on 01-04-2022, the firm maintains its operations in India.
Details regarding the target company and the acquisition structure are summarized below:
| Metric | Details |
|---|---|
| Target Entity Name | Aqua Marine |
| Industry | Manufacturing of fish meals and fish oil |
| Stake Acquired | 51% |
| Acquisition Cost Limit | Not exceeding Rs. 15,00,00,000/- (Cash) |
The financial profile of Aqua Marine shows consistent growth across the reported fiscal years:
| Year | Financial Metric | Value |
|---|---|---|
| FY 2024-25 | Turnover | Rs. 32,15,07,660/- |
| FY 2024-25 | PAT | Rs. 1,067,656/- |
| March 2023 | Turnover | Rs. 1,72,94,750/- |
| March 2024 | Turnover | Rs. 54,67,36,135/- |
MUKKA Stock Price Movement
Today, Mukka Proteins Limited shares edged significantly higher, closing at ₹22.81 after rallying by 8.74%, or ₹1.84, in the market session. The stock traded within a range of ₹21.06 and ₹23.2, with strong buying action recorded throughout the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.